Targeting ERα degradation by L-Tetrahydropalmatine provides a novel strategy for breast cancer treatment

The incidence and mortality of breast cancer (BCa) are the highest among female cancers. There are approximate 70% BCa that are classified as estrogen receptor alpha (ERα) positive. Therefore, targeting ERα is the most significantly therapeutic schedule. However, patients with breast cancer develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Xiaohong, He, Jinchan, Liu, Bin, Shao, Zhenlong, Xu, Qiong, Hu, Tumei, Yu, Cuifu, Liu, Xiaolin, Liao, Yuning, Liu, Ningning, Huang, Hongbiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294940/
https://www.ncbi.nlm.nih.gov/pubmed/32549765
http://dx.doi.org/10.7150/ijbs.44005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294940/
https://www.ncbi.nlm.nih.gov/pubmed/32549765
http://dx.doi.org/10.7150/ijbs.44005

Ejemplares similares